NCT06208865

Brief Summary

This study aimed to investigate the relationship between fatty infiltration in the lumbar paraspinal (multifidus and erector spinae) muscles, clinical characteristics, and treatment response after lumbar erector spinae plane block (ESPB) in patients with low back pain due to lumbar radiculopathy. A responder was defined as a patient with a numerical rating scale (NRS) decrease of ≥ 50% from baseline to one month after the procedure. The presence of fat infiltration in the lumbar paraspinal muscles was assessed, along with patient demographic and clinical characteristics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
147

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 2, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 17, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 17, 2024

Completed
Last Updated

April 8, 2024

Status Verified

April 1, 2024

Enrollment Period

8 months

First QC Date

December 17, 2023

Last Update Submit

April 5, 2024

Conditions

Keywords

plane blocklow back painlumbar radiculopathyfatty infiltrationerector spinae muscles

Outcome Measures

Primary Outcomes (1)

  • VAS

    Visual analogue scales (VAS) are psychometric measuring instruments designed to document the characteristics of disease-related symptom severity in individual patients and use this to achieve a rapid (statistically measurable and reproducible) classification of symptom severity and disease control.

    Change from Baseline NRS at 3 months

Interventions

All procedures were performed under ultrasound (US) guidance. The patient was monitored in the operating room and placed in the prone position under a sterile drape. A 2-6 MHz convex US probe was used during the procedure. The transverse processes of the lumbar vertebrae were visualized and then a 22 gauge spinal needle was advanced to the transverse process of the L3 vertebra. After contacting the transverse process, a total of 15 mL of drug consisting of 2 mL of methylprednisolone and 6 mL of 0.025% bupivacaine was injected into this area, and the spread of the drug in the craniocaudal area was visualized. The patients were followed up for possible complications after the procedure.

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Male and female patients who underwent lumbar erector spinae plane block for low back pain due to lumbar radiculopathy

You may qualify if:

  • lumbar radicular pain
  • no response to conservative treatment for \> 3 months
  • MRI within 1 year prior to injection.

You may not qualify if:

  • inadequate medical records with missing numerical rating scale (NRS) scores and MRI images
  • patients lost to follow-up within one month after lumbar ESPB
  • patients with a history of surgery for lumbar disc herniation
  • patients with severe spinal and/or foraminal stenosis
  • patients with extruded, sequestrated, or migrating hernias.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Low Back PainRadiculopathy

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Ömer Taylan Akkaya, MD

    Diskapi Teaching and Research Hospital

    PRINCIPAL INVESTIGATOR
  • Ezgi Can, MD

    Diskapi Teaching and Research Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor

Study Record Dates

First Submitted

December 17, 2023

First Posted

January 17, 2024

Study Start

November 1, 2022

Primary Completion

July 1, 2023

Study Completion

July 2, 2023

Last Updated

April 8, 2024

Record last verified: 2024-04

Locations